NCT02050386

Brief Summary

This is a study designed to look at how arousal levels in the brain change with age and how these changes influence thinking, vision, hearing and physical function in people of advanced age.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2013

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 23, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 30, 2014

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

December 19, 2016

Status Verified

December 1, 2016

Enrollment Period

1.6 years

First QC Date

January 23, 2014

Last Update Submit

December 16, 2016

Conditions

Keywords

Brain arousal systemsAgingMRIfMRICognition

Outcome Measures

Primary Outcomes (4)

  • Cognitive Function

    The Cognition Domain measures several aspects of cognitive functioning for ages 3-85, including language, episodic memory, executive function, working memory and processing speed. To interpret individual performance, one can evaluate all three types of scale scores. A participant's age-adjusted scale score at or near 100 indicates vocabulary ability that is average for the age level. Scores around 115 suggest above-average vocabulary ability, while scores around 130 suggest superior ability.

    Baseline

  • MRI: BOLD Response

    Functional MRI

    Baseline

  • Cognitive Function

    The Cognition Domain measures several aspects of cognitive functioning for ages 3-85, including language, episodic memory, executive function, working memory and processing speed. To interpret individual performance, one can evaluate all three types of scale scores. A participant's age-adjusted scale score at or near 100 indicates vocabulary ability that is average for the age level. Scores around 115 suggest above-average vocabulary ability, while scores around 130 suggest superior ability.

    up to 30 days

  • MRI: BOLD Response

    Functional MRI

    up to 30 days

Secondary Outcomes (5)

  • Physiological Response: Mean Heart Rate

    Baseline

  • Cognitive Functions: N-Back Task Test

    Baseline

  • Cognitive Functions: Attention Tasks Test

    Baseline

  • Cognitive Functions: Memory Task Test

    Baseline

  • Physical Function: Short Physical Performance Battery

    Baseline

Study Arms (2)

Cold pressor stimulation

Immersion of the foot in 0-2 degrees C water for 50 seconds.

Other: Cold pressor stimulation

Sham Stimulation

Immersion of the foot in room temperature water for 50 seconds.

Other: Sham Stimulation

Interventions

Immersion of the foot in 0-2 degrees C water for 50 seconds

Cold pressor stimulation

Immersion of the foot in room temperature water for 50 seconds

Sham Stimulation

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy adults 18 and older.

You may qualify if:

  • Ages 18 to 95

You may not qualify if:

  • History of pre-existing neurological disorders,
  • Psychiatric brain disorders,
  • Diagnosis with a neurodegenerative brain disease,
  • Uncontrolled blood pressure (\>200/110),
  • History of severe hypertension,
  • History of angina
  • People who have metal implants and can not have an MRI scan,
  • People who are claustrophobic,
  • Females of child-bearing age and have a positive test for pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Florida

Gainesville, Florida, 32610, United States

Location

Study Officials

  • Adam J Woods, PhD

    University of Florida

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2014

First Posted

January 30, 2014

Study Start

November 1, 2013

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

December 19, 2016

Record last verified: 2016-12

Locations